Advertisement
Screener

MEREO BIOPHARMA GROUP PLC (MREO) Derivative Liability, Noncurrent

2.8 / 5 stars · 68/120 Roast Me

MEREO BIOPHARMA GROUP PLC Derivative Liability, Noncurrent

MEREO BIOPHARMA GROUP PLC (MREO) had Derivative Liability, Noncurrent of $15.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-11.

Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent

us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2026-08-11

  • 2026-06-30: Derivative Liability, Noncurrent $15.00K.
  • 2026-03-31: Derivative Liability, Noncurrent $21.00K.
  • 2025-12-31: Derivative Liability, Noncurrent $38.00K.
  • 2025-09-30: Derivative Liability, Noncurrent $336.00K.
Period endDerivative Liability, Noncurrent
2026-06-30$15.00K
10-Q · filed 2026-08-11
2026-03-31$21.00K
10-Q · filed 2026-05-12
2025-12-31$38.00K
10-Q · filed 2026-08-11
2025-09-30$336.00K
10-Q · filed 2025-11-10
2025-06-30$545.00K
10-Q · filed 2025-08-12
2025-03-31$419.00K
10-Q · filed 2025-05-13
2024-12-31$821.00K
10-K · filed 2026-03-19
2024-09-30$1.04M
10-Q · filed 2024-11-12
2024-06-30$925.00K
10-Q · filed 2024-08-13
2024-03-31$855.00K
10-Q · filed 2024-05-15
2023-12-31$412.00K
10-K · filed 2025-03-26
2022-12-31$157.00K
10-K · filed 2024-03-27

Similar stocks

Stock NameCountryMarket CapPE Ratio
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Sagimet Biosciences Inc. (SGMT)United States$0.279B
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35
Upstream Bio, Inc. (UPB)United States$0.284B-2.42
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78